OHSU develops prostate cancer drug
- Written by Oregon Business Team
- Published in News
- 0 comments
There is a promising development in the fight against prostate cancer.
There is a promising development in the fight against prostate cancer.
Researchers at Oregon Health & Science University's Knight Cancer Institute conducted a double blind study, testing a new drug called Enzalutamide.
Half of the 1,700 patients got the real pill. The other half got a placebo. Results were so impressive that researchers stopped the trial and gave the pill to the placebo group, too.
Read more at KGW.
Last modified onMonday, 19 October 2015 11:41
Latest from Oregon Business Team
- The 2023 100 Best Companies to Work for in Oregon survey is open!
- New for the 2023 Survey: Customized, Supplemental 100 Best Survey Questions
- Fresh Solutions for Flexible Workplaces
- Hop In! How Shared Rides Boost Staff Benefits
- Recruit, retain employees + create thriving workplaces by leveraging low-cost commute benefits